7 research outputs found
Examining the Association of Trait-like vs. In-Vivo Catastrophizing and Experimental Pain Sensitivity
Catastrophizing cognitions, consisting of rumination, helplessness, and magnification, are associated with increased pain intensity and pain behaviors in individuals with chronic pain. Trait-like catastrophizing refers to levels of catastrophizing related to general past pain experiences. In-vivo catastrophizing refers to levels of catastrophizing related to a specific pain event, usually one that has just occurred. The current study examined the extent to which trait-like and in-vivo pain catastrophizing are differentially related to experimental pain tolerance. We hypothesized that: 1) In-vivo catastrophizing would have a stronger relationship with pain tolerance than trait-like catastrophizing. 2) Different components of catastrophizing (i.e. rumination, helplessness, and magnification) would be differentially related to pain tolerance.This study was supported by the Department of Psychology Research Award
Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery
Choline kinase α (ChoKα)
is an enzyme involved in the
synthesis of phospholipids and thereby plays key roles in regulation
of cell proliferation, oncogenic transformation, and human carcinogenesis.
Since several inhibitors of ChoKα display antiproliferative
activity in both cellular and animal models, this novel oncogene has
recently gained interest as a promising small molecule target for
cancer therapy. Here we summarize our efforts to further validate
ChoKα as an oncogenic target and explore the activity of novel
small molecule inhibitors of ChoKα. Starting from weakly binding
fragments, we describe a structure based lead discovery approach,
which resulted in novel highly potent inhibitors of ChoKα. In
cancer cell lines, our lead compounds exhibit a dose-dependent decrease
of phosphocholine, inhibition of cell growth, and induction of apoptosis
at low micromolar concentrations. The druglike lead series presented
here is optimizable for improvements in cellular potency, drug target
residence time, and pharmacokinetic parameters. These inhibitors may
be utilized not only to further validate ChoKα as antioncogenic
target but also as novel chemical matter that may lead to antitumor
agents that specifically interfere with cancer cell metabolism
Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery
Choline kinase α (ChoKα)
is an enzyme involved in the
synthesis of phospholipids and thereby plays key roles in regulation
of cell proliferation, oncogenic transformation, and human carcinogenesis.
Since several inhibitors of ChoKα display antiproliferative
activity in both cellular and animal models, this novel oncogene has
recently gained interest as a promising small molecule target for
cancer therapy. Here we summarize our efforts to further validate
ChoKα as an oncogenic target and explore the activity of novel
small molecule inhibitors of ChoKα. Starting from weakly binding
fragments, we describe a structure based lead discovery approach,
which resulted in novel highly potent inhibitors of ChoKα. In
cancer cell lines, our lead compounds exhibit a dose-dependent decrease
of phosphocholine, inhibition of cell growth, and induction of apoptosis
at low micromolar concentrations. The druglike lead series presented
here is optimizable for improvements in cellular potency, drug target
residence time, and pharmacokinetic parameters. These inhibitors may
be utilized not only to further validate ChoKα as antioncogenic
target but also as novel chemical matter that may lead to antitumor
agents that specifically interfere with cancer cell metabolism
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study
BACKGROUND:
The National Research Council (CNR) prostate cancer monitoring project in Italy (Pros-IT CNR) is an observational, prospective, ongoing, multicentre study aiming to monitor a sample of Italian males diagnosed as new cases of prostate cancer. The present study aims to present data on the quality of life at time prostate cancer is diagnosed.
METHODS:
One thousand seven hundred five patients were enrolled. Quality of life is evaluated at the time cancer was diagnosed and at subsequent assessments via the Italian version of the University of California Los Angeles-Prostate Cancer Index (UCLA-PCI) and the Short Form Health Survey (SF-12).
RESULTS:
At diagnosis, lower scores on the physical component of the SF-12 were associated to older ages, obesity and the presence of 3+ moderate/severe comorbidities. Lower scores on the mental component were associated to younger ages, the presence of 3+ moderate/severe comorbidities and a T-score higher than one. Urinary and bowel functions according to UCLA-PCI were generally good. Almost 5% of the sample reported using at least one safety pad daily to control urinary loss; less than 3% reported moderate/severe problems attributable to bowel functions, and sexual function was a moderate/severe problem for 26.7%. Diabetes, 3+ moderate/severe comorbidities, T2 or T3-T4 categories and a Gleason score of eight or more were significantly associated with lower sexual function scores at diagnosis.
CONCLUSIONS:
Data collected by the Pros-IT CNR study have clarified the baseline status of newly diagnosed prostate cancer patients. A comprehensive assessment of quality of life will allow to objectively evaluate outcomes of different profile of care
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)
Background: To report health-related quality of life outcomes as assessed by validated patient-reported outcome measures (PROMs) after radical prostatectomy (RP).-Methods: This study analyzed patients treated with RP within The PROState cancer monitoring in Italy, from the National Research Council (Pros-IT CNR). Italian versions of Short-Form Heath Survey and university of California los Angeles-prostate cancer index questionnaires were administered. PROMs were physical composite scores, mental composite scores and urinary, bowel, sexual functions and bothers (UF/B, BF/B, SF/B). Baseline unbalances were controlled with propensity scores and stabilized inverse weights; differences in PROMs between different RP approaches were estimated by mixed models. Results: Of 541 patients treated with RP, 115 (21%) received open RP (ORP), 90 (17%) laparoscopic RP (LRP) and 336 (61%) robot-assisted RP (RARP). At head-to-head-comparisons, RARP showed higher 12-month UF vs. LRP (interaction treatment 17 time p = 0.03) and 6-month SF vs. ORP (p < 0.001). At 12-month from surgery, 67, 73 and 79% of patients used no pad for urinary loss in ORP, LRP and RARP respectively (no differences for each comparison). Conversely, 16, 27 and 40% of patients declared erections firm enough for sexual intercourse in ORP, LRP and RARP respectively (only significant difference for ORP vs. RARP, p = 0.0004). Conclusions: Different RP approaches lead to significant variations in urinary and sexual PROMs, with a general trend in favour of RARP. However, their clinical significance seems limited
Impact of Surgical Approach on Patient-Reported Outcomes after Radical Prostatectomy: A Propensity Score-Weighted Analysis from a Multicenter, Prospective, Observational Study (The Pros-IT CNR Study)
Background: To report health-related quality of life outcomes as assessed by validated patient-reported outcome measures (PROMs) after radical prostatectomy (RP).-Methods: This study analyzed patients treated with RP within The PROState cancer monitoring in Italy, from the National Research Council (Pros-IT CNR). Italian versions of Short-Form Heath Survey and university of California los Angeles-prostate cancer index questionnaires were administered. PROMs were physical composite scores, mental composite scores and urinary, bowel, sexual functions and bothers (UF/B, BF/B, SF/B). Baseline unbalances were controlled with propensity scores and stabilized inverse weights; differences in PROMs between different RP approaches were estimated by mixed models. Results: Of 541 patients treated with RP, 115 (21%) received open RP (ORP), 90 (17%) laparoscopic RP (LRP) and 336 (61%) robot-assisted RP (RARP). At head-to-head-comparisons, RARP showed higher 12-month UF vs. LRP (interaction treatment â time p = 0.03) and 6-month SF vs. ORP (p < 0.001). At 12-month from surgery, 67, 73 and 79% of patients used no pad for urinary loss in ORP, LRP and RARP respectively (no differences for each comparison). Conversely, 16, 27 and 40% of patients declared erections firm enough for sexual intercourse in ORP, LRP and RARP respectively (only significant difference for ORP vs. RARP, p = 0.0004). Conclusions: Different RP approaches lead to significant variations in urinary and sexual PROMs, with a general trend in favour of RARP. However, their clinical significance seems limited. © 2018 S. Karger AG, Basel. All rights reserved